Clinical Trial Update: The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravenous glucocorticoids on tearfilm in patients with thyroid-associated ophthalmopathy and dry eye syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Thyroid-associated Ophthalmopathy

Drugs mentioned

• glucocorticoids (glucocorticoids)

Snippet

Sponsor: Medical University of Vienna | Conditions: Thyroid-associated Ophthalmopathy, Dry Eye Syndrome | Phase 3 | Status: COMPLETED